Miller Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Miller Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.2K	Hold	281	–	–	0.01%	64
2026 Q1	$17K	Buy	281 +4	+1%	+$233	0.01%	62
2025 Q4	$15K	Buy	277 +3	+1%	+$144	0.01%	62
2025 Q3	$12.3K	Buy	274 +4	+1%	+$187	0.01%	71
2025 Q2	$12.5K	Buy	270 +3	+1%	+$147	0.01%	60
2025 Q1	$16.3K	Buy	267 +3	+1%	+$175	0.01%	53
2024 Q4	$14.9K	Buy	264 +3	+1%	+$168	0.01%	48
2024 Q3	$13.9K	Buy	261 +3	+1%	+$141	0.01%	45
2024 Q2	$10.7K	Buy	258 +4	+2%	+$179	0.01%	51
2024 Q1	$13.8K	Buy	254 +3	+1%	+$153	0.01%	48
2023 Q4	$12.9K	Buy	251 +2	+0.8%	+$105	0.01%	45
2023 Q3	$14.4K	Buy	249 +3	+1%	+$184	0.01%	42
2023 Q2	$15.7K	Sell	246 -5,754	-96%	-$386K	0.01%	40
2023 Q1	$196K	Buy	6,000 +5,519	+1,147%	+$389K	0.95%	8
2022 Q4	$36K	Buy	481 +242	+101%	+$18.2K	0.03%	33
2022 Q3	$18K	Hold	239	–	–	0.01%	59
2022 Q2	$18K	Buy	239 +2	+0.8%	+$152	0.01%	50
2022 Q1	$17K	Buy	237 +2	+0.9%	+$134	0.01%	54
2021 Q4	$15K	Buy	+235	New	+$13.8K	0.01%	52

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Miller Wealth Advisors's BMY Position: Q2 2026 in Review

Miller Wealth Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 281 shares worth $16.2K. The position accounts for 0.01% of the portfolio, ranked #64.

Miller Wealth Advisors first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $196K in Q1 2023. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Miller Wealth Advisors held 281 shares of Bristol-Myers Squibb worth $16.2K as of Q2 2026.
Miller Wealth Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.01% of Miller Wealth Advisors's portfolio in Q2 2026, its #64 holding.
Miller Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
Miller Wealth Advisors's Bristol-Myers Squibb position peaked at $196K in Q1 2023.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.